Psychedelic Laws & Policy

New Mexico Just Opened Its First Psilocybin Permits. The One Clinicians Need Is Still Coming

New Mexico began accepting psilocybin producer applications on August 17. The clinician permit has not opened, and the end of 2026 target looks unlikely.

A Federal Report Just Told States to Prepare for Psychedelic Approval. Ketamine Clinics Are the Template

SAMHSA told states to build the budget, licensing, and oversight machinery for psychedelic therapy before the FDA approves anything. Ketamine is not named once.

Oregon Tracks Psilocybin Safety for Three Days. The New Data Found Problems at Three Months

A JAMA Network Open study followed 346 people through Oregon's licensed psilocybin program. The adverse events showed up long after the state stops looking.

England Has a Recreational Ketamine Crisis. Here Is How American Clinics Keep It From Happening Here

In one Manchester treatment cohort, 64 percent of the people being treated for ketamine problems were under 18. Forty two percent were between 13 and 16. That is what a recreational ketamine crisis looks like once it has fully arrived, and England is living in one. America is not, and the reason has less to […]

FDA Finalizes Psychedelic Trial Guidance, Then Opens A Bigger Federal Conversation

The FDA finalized its first formal guidance for studying psychedelic drugs. The document sets the ground rules for research into psilocybin, LSD, and MDMA.

Texas Keeps Rewriting Its Ketamine Rules. Here Is What Changed and What It Means for Your Clinic

The Texas Medical Board rewrote its proposed ketamine rules. The July 10 version is out. Here's what Texas clinics should do now.

Minnesota Moves Closer to Expanding Access to Psilocybin Therapy

Minnesota is moving closer to creating a regulated psilocybin therapy program, although legal access will not begin this year.

Congress Pushes To Turn Trump’s Psychedelic Therapy Order Into Law

A new bipartisan bill would take President Trump’s psychedelic therapy order and try to make it harder to undo.

The Clock Is Running on Ketamine Telehealth. Six Months Remain, and Many Clinics Are Not Ready

The DEA rules that power ketamine telemedicine expire December 31. The permanent rules will reshape platforms, prescribing, and referrals.

The FDA Just Showed Ketamine Clinics Exactly How a Crackdown Starts. Almost Nobody Noticed

The FDA's crackdown on compounded GLP-1 marketing is a preview for ketamine clinics. Your website copy may be your biggest liability.